Hikma Pharmaceuticals saw no growth in patent filings and highest growth of 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Hikma Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Hikma Pharmaceuticals has been focused on protecting inventions in United States(US) with five publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 100% filings and 100% grants. The United States(US) patent Office are among the top ten patent offices where Hikma Pharmaceuticals is filings its patents. Among the top granted patent authorities, Hikma Pharmaceuticals has 100% of its grants in United States(US).
AbbVie and Eli Lilly and Co could be the strongest competitors for Hikma Pharmaceuticals
Patents related to addiction lead Hikma Pharmaceuticals's portfolio
Hikma Pharmaceuticals has the highest number of patents in addiction. For addiction no patents were filed and 100% of patents were granted in Q2 2024.
Pain related patents lead Hikma Pharmaceuticals portfolio followed by myocardial infarction, and renal colic
Hikma Pharmaceuticals has highest number of patents in pain followed by myocardial infarction, renal colic, opium (opioid) addiction, and burns.
For comprehensive analysis of Hikma Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
